Paper Details

  1. Home
  2. Paper Details

Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions.

Author: Banu RekhaV V, JawaharM S, KripasankarA S, NiruparaniC, ParthasarathyR, RajaramK, SelvakumarN, SheikhI, SridharR, UmapathyK C, VictorM

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

The thrice-weekly regimen of antitubercular drugs (2H(3)R(3)Z(3)E(3)/4H(3)R(3)) was effective and well-tolerated in HIV-negative patients with newly diagnosed smear-positive pulmonary tuberculosis.
Paper Details　
Original Abstract of the Article :
Under the Revised National Tuberculosis Control Programme of India, patients with new smear-positive pulmonary tuberculosis are treated with a thrice-weekly regimen of antitubercular drugs (2H(3)R(3)Z(3)E(3)/4H(3)R(3) [H isoniazid, R rifampicin, Z pyrazinamide and E ethambutol]) for 6 months. We con...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23278775

データ提供：米国国立医学図書館（NLM）

Evaluating the Efficacy of a Short-Course Regimen for Tuberculosis Treatment

This study explores the world of infectious disease control, focusing on the treatment of pulmonary tuberculosis. It's like embarking on a journey through the desert sands, seeking the most effective weapons to combat a dangerous foe.

The researchers investigated the efficacy of a thrice-weekly regimen of antitubercular drugs for a six-month duration. They carefully analyzed data from HIV-negative patients with newly diagnosed pulmonary tuberculosis. This is like studying the effects of different types of desert plants on the surrounding ecosystem.

The study provides crucial insights into the treatment of tuberculosis, offering valuable information for healthcare professionals and patients. It's a beacon of hope in the fight against this devastating disease.

A Promising Approach to Tuberculosis Treatment

The study found that the thrice-weekly regimen was effective in treating new sputum smear-positive pulmonary tuberculosis, offering a potentially shorter and more convenient treatment option for patients. This is like finding a more efficient route through the desert, leading to a faster and easier journey.

Combating Tuberculosis: A Collective Effort

The research emphasizes the importance of ongoing research and development of effective treatment regimens for tuberculosis, as well as the need for continued collaboration between healthcare professionals and researchers. It's a testament to the power of teamwork in overcoming challenges and finding solutions.

Dr. Camel's Conclusion

This study highlights the importance of ongoing research and development of effective treatment regimens for tuberculosis, as well as the need for continued collaboration between healthcare professionals and researchers. It's a testament to the power of teamwork in overcoming challenges and finding solutions.

Date :
  1. Date Completed 2013-04-19
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

23278775

DOI: Digital Object Identifier

23278775

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.